Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre …

C Laurent, C Kouanfack, S Koulla-Shiro, N Nkoué… - The Lancet, 2004 - thelancet.com
Background Generic fixed-dose combinations have been prequalified by WHO to treat HIV-
infected patients in resource-limited countries. Despite their widespread use they are …

Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program

EO Idigbe, TA Adewole, G Eisen, P Kanki… - JAIDS Journal of …, 2005 - journals.lww.com
Objective: To evaluate treatment outcome in the first 12 months among HIV-positive patients
managed with a combination of nevirapine+ stavudine+ lamivudine under the current …

Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.

RFA L'homme, D Kabamba, FM Ewings… - AIDS (London …, 2008 - europepmc.org
Objective Triomune Baby and Junior have been developed in response to the urgent need
for appropriate paediatric fixed-dose combination antiretroviral tablets, with higher …

Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized …

E DeJesus, D McCarty, CF Farthing… - Clinical infectious …, 2004 - academic.oup.com
A randomized, double-blind, double-dummy controlled, multicenter trial was conducted that
involved 554 antiretroviral-naive human immunodeficiency virus—infected adults (plasma …

Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia

JC Ellis, RFA L'homme, FM Ewings… - Antiviral …, 2007 - journals.sagepub.com
Objective To investigate nevirapine concentrations in African HIV-infected children receiving
divided Triomune tablets (stavudine+ lamivudine+ nevirapine). Design Cross-sectional …

Effectiveness of generic fixed-dose combinations of highly active antiretroviral therapy for treatment of HIV infection in India

SN Pujari, AK Patel, E Naik, KK Patel… - JAIDS Journal of …, 2004 - journals.lww.com
Objective: To assess clinical and immunologic effectiveness and acute toxicity to nevirapine
(NVP)-based fixed-dose combinations (FDCs) in antiretroviral-naive HIV-1-infected patients …

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label …

F van Leth, P Phanuphak, K Ruxrungtham, E Baraldi… - The Lancet, 2004 - thelancet.com
Summary Background The 2NN Study was a randomised comparison of the non-nucleoside
reverse-transcriptase inhibitors (NNRTI) nevirapine and efavirenz. Methods In this …

A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study)

D Podzamczer, E Ferrer, E Consiglio… - Antiviral …, 2002 - journals.sagepub.com
Background Non-nucleoside reverse transcriptase inhibitor-containing regimens may be a
valid alternative to protease inhibitor-containing regimens for initial antiretroviral therapy, but …

Experience with the use of a first‐line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database

J Zhou, NI Paton, R Ditangco, YMA Chen… - HIV …, 2007 - Wiley Online Library
Background The antiretroviral treatment (ART) combination of stavudine, lamivudine and
nevirapine (d4T/3TC/NVP) is the most frequently used initial regimen in many Asian …

Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus

SH Cheeseman, D Havlir, MM McLaughlin… - JAIDS Journal of …, 1995 - journals.lww.com
In these Phase I/II open-label clinical trials, 62 persons with human immunodeficiency virus
type 1 (HIV-1) infection and CD4+ cell counts<= 400/mm3 received nevirapine at doses of …